Sort   by:  
 Page size 
ProteomicsCD95/Fas suppresses NF-B activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
CD95 expression is preserved in triple-negative breast cancers (TNBCs) and CD95 loss in these cells triggers the induction of a pro-inflammatory program promoting the recruitment of cytotoxic NK cells impairing tumor growth. Herein, we identify a novel interaction partner of CD95, Kip1 ubiquitinatio...
ORGANISM(S): Homo sapiens (Human) 
2021-12-06 | PXD027196 | Pride
Kpc2 Inflammation Nf-kappab Fas P65 
GenomicsscATAC seq. on KPC2 PDAC
scATAC seq. on KPC2 PDAC
PRJNA1484489 | ENA
GenomicsscATAC seq. on KPC2 PDAC
Orthotopic KPC2 mice were treated with indicated treatments for 2 weeks and subsequently sac'd to perform sc-ATAC seq. on sorted Live>CD45+ cells
ORGANISM(S): Mus musculus 
2026-07-01 | GSE337211 | GEO
UnknownRole of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle.
Not available
S-EPMC1265808 | biostudies-literature
GenomicsBioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Klebsiella pneumoniae KPC2
Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Klebsiella pneumoniae KPC2
PRJNA640631 | ENA
UnknownCD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism.
Not available
S-EPMC8666665 | biostudies-literature
TranscriptomicsBioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Klebsiella pneumoniae KPC2
The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: Escherichia col...
ORGANISM(S): Klebsiella pneumoniae 
2021-07-01 | GSE152843 | GEO
GenomicsKlebsiella pneumoniae subsp. pneumoniae KpMDU1
An Australian Klebsiella pneumoniae isolate bearing the KPC2 carbapenemase
PRJNA174122 | ENA
GenomicsCitrobacter freundii strain:CF121SC21 | isolate:CF121SC21 plasmid KPC2
Citrobacter freundii strain:CF121SC21 | isolate:CF121SC21 plasmid KPC2 Genome sequencing
PRJNA376865 | ENA
UnknownIn vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae.
Not available
S-EPMC5472793 | biostudies-literature
Sort   by:  
 Page size